Skip to main content
Signal8

Calithera Biosciences, Inc. (CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Sector: Biotechnology

Industry: Biotechnology

OTC:CALA

    Calithera Biosciences, Inc. (CALA) SEC Filings | Signal8